SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.67-2.1%1:41 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: T. Mann who wrote (97)4/14/1997 8:33:00 AM
From: Gerald Thomas   of 455
 
I believe it is a small molecule substance based on 3d structure
of binding sites on t-cells to help modulate immune responses. In other words it affixes itself to the binding sites on t-cells for hiv blocking entry through the portal...
You can find out more through procept.com

and I believe they have a patent on it as well that should be listed......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext